Navigation Links
Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
Date:2/18/2011

nce as there is a large un-met medical need for new treatments for ovarian cancer which has a very high morbidity rate. CVac™ is a maintenance therapy administered post-surgery and post-chemotherapy to delay relapse and control metastases.

There are currently no products available as maintenance based therapies for ovarian cancer and the global market for ovarian cancer therapeutics was valued at US$2.1b in 2007 and is expected to total US$3.6b by 2010.

Regulatory approval and commercialisation of CVac™ is the core focus for Prima.

About Prima BioMedPrima BioMed is an ASX listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology. Prima's lead product is the CVac™ ovarian cancer therapy treatment. It has completed two successful clinical trials and is progressing toward eventual commercialisation in the United States, Australia, Europe, and globally.

The Company's broader, long term goal is to develop commercial cancer treatment technologies and programs for global markets.

Clinical AppendixStudy Title CAN-004: A Randomized, Double-Blinded, Placebo-Controlled Phase 2/3 Trial of CVac™ (Autologous Dendritic Cells Pulsed with Recombinant Human Fusion Protein [Mucin1-Glutathione S Transferase] Coupled to Oxidized Polymannose) as Maintenance Treatment in Patients With Epithelial Ovarian Cancer (EOC) Following Optimal Debulking Surgery and First-line Chemotherapy

Study DesignThis is a randomized, double-blinded, placebo-controlled Phase 2/3 trial of CVac as maintenance treatment in patients with EOC following optimal debulking surgery and first-line chemotherapy. The initial planned enrollment is 750 patients. The primary analysis of irPFS is planned to be conducted after 350 irPFS events (confirmed immune-related progressive disease [irPD] or death) have occurred. The primary analysis for OS is planned to be
'/>"/>

SOURCE Prima BioMed Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. New Research May Lead to Earlier Diagnosis and Treatment of Primary Biliary Cirrhosis in Families
4. ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
5. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
6. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
9. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
10. Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM)
11. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , Mar. 02, 2015 Research and Markets ... addition of the "Lopinavir - Comprehensive patent ... Imagine having your own team of ... button. Used by the world,s leading ... years, these searches are the benchmark in comprehensive, ...
(Date:3/2/2015)... Shire plc (LSE: SHP, NASDAQ: SHPG ... Drug Application (NDA) with the U. S. Food and Drug ... signs and symptoms of dry eye disease in adults. ... to address both the signs and symptoms of dry eye ... said Philip J. Vickers , Ph.D., Head of Research ...
(Date:3/2/2015)... , March 2, 2015 The Economist ... London last week on 26 February was host to ... on a number of topical issues facing the sector. This year,s ...   E ra , , observed the challenges the ... them. Panel speakers offered contrasting and thought-provoking commentary on ...
Breaking Medicine Technology:Global Comprehensive Lopinavir Patent Search Online Portal 2015 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 2Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 3Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults 421 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 221 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 321 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 421 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 521 Years of Debate: The Pharmaceutical Industry Convenes at The Economist Events' Pharma Summit 2015 to Discuss The Dawn of a New Era for the Industry 6
(Date:3/2/2015)... March 02, 2015 Doctors in Novara, ... a better predictor of outcomes for people with mesothelioma ... details of the new study on the Surviving ... the University of Eastern Piedmont followed the cases of ... treatment for excess lung fluid. , “Persistent lung ...
(Date:3/2/2015)... 02, 2015 Burns Engineering's Lab-to-Lab ... for Secondary Standard Platinum Resistance Thermometers (SSPRTs) and ... days or less . . . guaranteed. ... Accredited (Lab Code 200706-0), ISO 9001 and 17025 ... range is -196°C to 500°C, both ITS-90 and ...
(Date:3/2/2015)... The minimally invasive surgical instruments market is expected ... reach $14,133.0 million by 2019 from $10,526.2 million ... of minimally invasive surgeries over traditional open surgeries, ... and increasing number of surgical procedures among the ... surgical instruments market. , For More Details @ ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... Bangladesh (PRWEB) March 02, 2015 The ... of fire safety expert Mark Chubb to serve as ... fire safety operations and training in Bangladesh and guide ... source. , “Mark will ensure that the Alliance ... fire safety programs for Bangladesh garment workers,” said Alliance ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2
... flu antibodies in migrant birds in five Siberian regions, a ... ,"Out of over 4,000 samples taken in the area ... contain genetic material of the A-H5 virus and antibodies in ... said the presence of antibodies meant that either the birds ...
... two studies indicate that elevated nonfasting triglyceride levels ... heart attack , with one study finding that ... this association. ,Triglyceride levels are usually ... certain types of lipoprotein particles (remnant lipoproteins), a ...
... they have been discharged from hospital for an asthma attack ... Review has found. Giving the steroids also reduces their use ... ,This updated finding was drawn after reviewing data in ... and 16% of people who are discharged from hospital after ...
... and exercise is a more effective way of losing weight ... gain weight during pregnancy and many gradually lose it afterwards, ... weight. This retained body weight may be one factor that ... find ways of returning to, and maintaining, pre-pregnant weights, and ...
... Cochrane Systematic Review has concluded,Spraying salty water (saline) into ... and congestion that accompany long-term infections of the ... people experience persistent infection of the nasal passages (chronic ... spraying saline into the nose to relieve symptoms, and ...
... heart beats and have a tendency to form blood clots ... clots can then travel to the brain, block vessels and ... risk of this occurring is to give drugs that limit ... are anticoagulants that inhibit the clotting process (e.g. warfarin), and ...
Cached Medicine News:Health News:High Nonfasting Triglyceride Levels Linked With Cardiovascular Risks 2Health News:Anticoagulants is Better for Atrial Fibrillation 2
Inquire...
... false signals and contamination caused by ... Barrier Tips offer performance and economy ... (PCR(a)), radioactive isotopes, tissue culture fluids, ... , ,Promega Barrier Tips are made ...
... Filters are ideal for PCR ... for any work where aerosol ... designed for pipetting DNA/RNA solutions, ... other. For applications requiring absolute ...
... tips eliminate false signals and contamination ... tested, Promega Barrier Tips offer performance ... nucleic acids (PCR(a)), radioactive isotopes, tissue ... serological specimens. , ,Promega Barrier Tips ...
Medicine Products: